Evidence map›Paper›PMID 37120537›Full record

ArticleBiomedical engineering online2023

Machine learning application for classification of Alzheimer's disease stages using

Sang Won Park, Na Young Yeo, Jinsu Lee, Suk-Hee Lee, Junghyun Byun, Dong Young Park, Sujin Yum, Jung-Kyeom Kim, Gihwan Byeon, Yeshin Kim and 2 more

Open access · goldAbstract read
In one paragraph

Article in Biomedical engineering online, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Sang Won ParkDepartment of Neurology, Kangwon National University Hospital, 156, Baengnyeong-ro, Chuncheon, Gangwon, 24289, Republic of Korea.
Na Young YeoDepartment of Neurology, Kangwon National University Hospital, 156, Baengnyeong-ro, Chuncheon, Gangwon, 24289, Republic of Korea.
Jinsu LeeDepartment of Data Science Research Center, Seoul National University Hospital, Seoul, Korea.
Suk-Hee LeeDepartment of Statistics, Kangwon National University, Chuncheon, Korea.
Junghyun ByunDepartment of Healthcare, Radiation Health Institute, Hydro & Nuclear Co., Ltd., Seongnam, Korea.
Dong Young ParkDepartment of Neurology, Kangwon National University Hospital, 156, Baengnyeong-ro, Chuncheon, Gangwon, 24289, Republic of Korea.
Sujin YumDepartment of Neurology, Kangwon National University Hospital, 156, Baengnyeong-ro, Chuncheon, Gangwon, 24289, Republic of Korea.
Jung-Kyeom KimDepartment of Neurology, Kangwon National University Hospital, 156, Baengnyeong-ro, Chuncheon, Gangwon, 24289, Republic of Korea.
Gihwan ByeonSchool of Medicine, Kangwon National University, Chuncheon, Korea.
Yeshin KimDepartment of Neurology, Kangwon National University Hospital, 156, Baengnyeong-ro, Chuncheon, Gangwon, 24289, Republic of Korea.
Jae-Won JangDepartment of Neurology, Kangwon National University Hospital, 156, Baengnyeong-ro, Chuncheon, Gangwon, 24289, Republic of Korea. jaewon26@gmail.com.
Alzheimer’s Disease Neuroimaging Initiative
Kangwon National University · KRKangwon National University Hospital · KRSeoul National University Hospital · KR

Funding

Basic Science Research Program through the National Research Foundation of Korea (NRF) NRF 2021R1I1A3059241
6 · The paper itself

Abstract

backgroundThe progression of Alzheimer's dementia (AD) can be classified into three stages: cognitive unimpairment (CU), mild cognitive impairment (MCI), and AD. The purpose of this study was to implement a machine learning (ML) framework for AD stage classification using the standard uptake value ratio (SUVR) extracted from

resultsOf a total of 199 participants, 74, 69, and 56 patients were in the CU, MCI, and AD groups, respectively; their mean age was 71.5 years, and 106 (53.3%) were men. In the classification between CU and AD, the effect of clinical and tau SUVR was high in all classification tasks and all models had a mean area under the receiver operating characteristic curve (AUC) > 0.96. In the classification between MCI and AD, the independent effect of tau SUVR in SVM had an AUC of 0.88 (p < 0.05), which was the highest compared to other models. In the classification between MCI and CU, the AUC of each classification model was higher with tau SUVR variables than with clinical variables independently, which yielded an AUC of 0.75(p < 0.05) in MLP, which was the highest. As an explanation by SHAP for the classification between MCI and CU, and AD and CU, the amygdala and entorhinal cortex greatly affected the classification results. In the classification between MCI and AD, the para-hippocampal and temporal cortex affected model performance. Especially entorhinal cortex and amygdala showed a higher effect on model performance than all clinical variables in the classification between MCI and CU.

conclusionsThe independent effect of tau deposition indicates that it is an effective biomarker in classifying CU and MCI into clinical stages using MLP. It is also very effective in classifying AD stages using SVM with clinical information that can be easily obtained at clinical screening.

Indexed as

Alzheimer DiseaseAgedCarbolinesFemaleHumansMachine LearningMalePositron-Emission Tomographytau Proteins7-(6-fluoropyridin-3-yl)-5H-pyrido(4,3-b)indoleCarbolinestau ProteinsAlzheimer's diseaseCognitive dysfunctionMachine learningPositron-emission tomographyTau proteins

Identifiers

PMID37120537
PMCPMC10149022
OpenAlexW4367367722

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.